TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 710312

Group type: EXPERIMENTAL
Intervention: Low-dose heparin (3 X 5000 IU/24 h)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Combined low-dose heparin and acetylsalicyl-lysine (given intravenously)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Increased heparin dosage (3 X 7500 IU/24 h)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Control group (not receiving any heparin)
Number of subjects: 113
Study: 31414266

Group type: EXPERIMENTAL
Intervention: Parent-based weight-loss treatment for children with ASD (PBT-ASD)
Number of subjects: 20
Study: 28809770

Group type: EXPERIMENTAL
Intervention: Home-based paired syphilis and HIV testing during pregnancy
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: Home-based paired syphilis and HIV testing postpartum
Number of subjects: 310

Group type: COMPARATOR
Intervention: HIV testing before syphilis test introduction
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: HIV testing with paired testing offered
Number of subjects: 310
Study: 25730000

Group type: EXPERIMENTAL
Intervention: Traditional Chinese Medicine (kidney-reinforcing and blood-activating), N = 35
Number of subjects: 70

Group type: COMPARATOR
Intervention: Routine follow-up (Control), N = 35
Number of subjects: 70
Study: 23618450

Group type: EXPERIMENTAL
Intervention: 1 session daily (OD)
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: 1 session weekly with optional deliberate practice (WD)
Number of subjects: 145

Group type: COMPARATOR
Intervention: 1 session weekly (C)
Number of subjects: 145

Group type: COMPARATOR
Intervention: 3 sessions daily (TD)
Number of subjects: 145
Study: 21067912

Group type: EXPERIMENTAL
Intervention: Calcium and magnesium infusions (Ca/Mg(+))
Number of subjects: 732

Group type: COMPARATOR
Intervention: No calcium and magnesium infusions (Ca/Mg(-))
Number of subjects: 732
Study: 20108552

Group type: EXPERIMENTAL
Intervention: Chlorhexidine gluconate 0.02%
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 16700640

Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioral Stress Management (CBSM) intervention
Number of subjects: 191

Group type: COMPARATOR
Intervention: Half-day educational seminar (Control)
Number of subjects: 191
Study: 15001406

Group type: EXPERIMENTAL
Intervention: Verbal Pain Scores (VPS)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Mean time to analgesic administration
Number of subjects: 150
Study: 11315920

Group type: EXPERIMENTAL
Intervention: Estrogen plus medroxy progesterone acetate (hormone therapy)
Number of subjects: 969

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 969
Study: 9278766

Group type: EXPERIMENTAL
Intervention: RT + HT
Number of subjects: 101

Group type: COMPARATOR
Intervention: RT alone
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Cumulative minimum thermal isoeffect dose (equivalent minutes at 43 degrees C)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: MINTIME > 42 degrees C (first treatment session)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: %sensors > 43 degrees C (peak, second treatment session)
Number of subjects: 101
Study: 8315435

Group type: EXPERIMENTAL
Intervention: Interferon alfa‐2a (50 x 10(6) U/m2 intramuscularly three times per week)
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Interferon alfa‐2a (gradually escalating doses from 3 to 36 x 10(6) U subcutaneously administered daily)
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Interferon alfa‐2a (daily)
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Interferon alfa‐2a (daily) + vinblastine (0.15 mg/kg every 3 weeks)
Number of subjects: 159

Group type: COMPARATOR
Intervention: Control group (vinblastine only)
Number of subjects: 159
Study: 3099564

Group type: EXPERIMENTAL
Intervention: Cimetidine 400 mg BID
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Cimetidine 800 mg HS
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Ranitidine 150 mg HS
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Cimetidine 1200 mg HS (nonrandomized)
Number of subjects: 8
Study: 30287607

Group type: EXPERIMENTAL
Intervention: Furosemide forced diuresis with matched hydration using the RenalGuard system
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard of care prehydration and posthydration
Number of subjects: 0
Study: 27646578

Group type: EXPERIMENTAL
Intervention: Fish Oil (FO) alone (1.9 g DHA + EPA/day)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: EGCG alone (600 mg/day)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Combination of FO and EGCG
Number of subjects: 89

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89
Study: 25039111

Group type: EXPERIMENTAL
Intervention: Child abuse history (abused girls)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Non-abused adolescents (control group)
Number of subjects: 84
Study: 22952184

Group type: EXPERIMENTAL
Intervention: Selenium supplementation (100 μg Se as l-selenomethionine)
Number of subjects: 255

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Selenium supplementation
Number of subjects: 255
Study: 20724342

Group type: EXPERIMENTAL
Intervention: High-dose telmisartan (2 mg/kg/d)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Low-dose telmisartan (1 mg/kg/d)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study: 18601636

Group type: EXPERIMENTAL
Intervention: Educational intervention via mail from community pharmacists, including educational material and encouragement to see a general practitioner for asthma management review.
Number of subjects: 1551

Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 1551
Study: 16251800

Group type: EXPERIMENTAL
Intervention: Fluoride mouth rinsing (FMR) on the first three and the last three schooldays every semester (group 2)
Number of subjects: 622

Group type: EXPERIMENTAL
Intervention: Fluoride mouth rinsing (FMR) on the first three schooldays every semester (group 1)
Number of subjects: 622

Group type: EXPERIMENTAL
Intervention: Fluoride mouth rinsing (FMR) on three consecutive days once a month during semesters (group 3)
Number of subjects: 622

Group type: EXPERIMENTAL
Intervention: Fluoride mouth rinsing (FMR) once every fortnight during semesters (group 4)
Number of subjects: 622

Group type: COMPARATOR
Intervention: Control group (no rinsing)
Number of subjects: 622
Study: 11872029

Group type: EXPERIMENTAL
Intervention: Digital rectal examination (DRE) and transrectal ultrasonography (TRUS) as initial screening tests
Number of subjects: 117
Study: 10091520

Group type: EXPERIMENTAL
Intervention: Nifedipine-GITS (NIF, 30 mg/d)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (HCTZ, 25 mg/d)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Nifedipine-GITS (NIF, 30 mg/d) + Hydrochlorothiazide (HCTZ, 25 mg/d)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 12
Study: 7751519

Group type: EXPERIMENTAL
Intervention: Cetirizine dihydrochloride 0.25 microgram/ml
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Cetirizine dihydrochloride 1.0 and 2.5 micrograms/ml
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Cetirizine 10 and 20 mg/day
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Cetirizine therapy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 1979241

Group type: EXPERIMENTAL
Intervention: 10 mg cetirizine b.i.d.
Number of subjects: 43

Group type: COMPARATOR
Intervention: 60 mg terfenadine b.i.d. (Control)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: cetirizine
Number of subjects: 43
Study: 6105244

Group type: EXPERIMENTAL
Intervention: Simple mastectomy and routine immediate postoperative radiotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Simple mastectomy alone (with radiotherapy later if disease recurred)
Number of subjects: 0
Study: 30569286

Group type: EXPERIMENTAL
Intervention: SonicFill (SF) with OptiBond FL (OFL, ER)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Tetric EvoCeram Bulk fill (TEC) with OptiBond FL (OFL, ER)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: x‐tra fil (XF) with OptiBond FL (OFL, ER)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: SonicFill (SF) with Xeno V+ (X, SE)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Tetric EvoCeram Bulk fill (TEC) with Xeno V+ (X, SE)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: x‐tra fil (XF) with Xeno V+ (X, SE)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Incremental layering technique with Premise (P)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Bulk-fill composites with Xeno V+ (X, SE)
Number of subjects: 128
Study: 28914246

Group type: EXPERIMENTAL
Intervention: CPP-ACP chewing gum
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Xylitol-containing chewing gum
Number of subjects: 60
Study: 26454838

Group type: EXPERIMENTAL
Intervention: N-Acetylcysteine (2400mg total, 1200mg b.i.d.)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 23695900

Group type: EXPERIMENTAL
Intervention: Phonomotor treatment (60 hours over 6 weeks)
Number of subjects: 10
Study: 21724087

Group type: EXPERIMENTAL
Intervention: Protocol II: toothbrushing + baseplate brushing + Periogard spraying on the seventh day after appliance placement
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Protocol III: toothbrushing + baseplate brushing + Periogard spraying on the fourth and seventh days after appliance placement
Number of subjects: 15

Group type: COMPARATOR
Intervention: Protocol I: toothbrushing + baseplate brushing + sterile tap water spraying once a day
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Scanning electron microscope analysis
Number of subjects: 15
Study: 19169143

Group type: EXPERIMENTAL
Intervention: 1.0 M gadobutrol (0.1 mmol/kg body weight)
Number of subjects: 572

Group type: COMPARATOR
Intervention: 0.5 M gadopentetate (0.1 mmol/kg body weight)
Number of subjects: 572

Group type: EXPERIMENTAL
Intervention: Both groups (1.0 M gadobutrol and 0.5 M gadopentetate)
Number of subjects: 572
Study: 15678052

Group type: EXPERIMENTAL
Intervention: Antiarrhythmic therapy for 1 week (group A)
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Antiarrhythmic therapy for 3 weeks (group B)
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Antiarrhythmic therapy for 6 weeks (group C)
Number of subjects: 129
Study: 12707430

Group type: EXPERIMENTAL
Intervention: Venlafaxine 225 mg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Imipramine 150 mg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Venlafaxine vs Imipramine
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Venlafaxine
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 40
Study: 10536913

Group type: EXPERIMENTAL
Intervention: Natural interferon-beta (nIFN-beta) 6 MIU intramuscularly three times a week for 24 months
Number of subjects: 98

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 98
Study: 8916821

Group type: EXPERIMENTAL
Intervention: High-dose tranexamic acid (maximum of 20 g)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 1670840

Group type: EXPERIMENTAL
Intervention: calcipotriol ointment 50 micrograms/g
Number of subjects: 345

Group type: COMPARATOR
Intervention: betamethasone valerate ointment 0.1%
Number of subjects: 345
Study: 6226926

Group type: EXPERIMENTAL
Intervention: Vitamin/mineral supplementation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 30924154

Group type: EXPERIMENTAL
Intervention: DSP-0565 administered orally to rats and dogs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: In vitro-in vivo extrapolation (IVIVE) with animal scaling factors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Use of scaling factors for hydrolysis pathway
Number of subjects: 0
Study: 29916979

Group type: EXPERIMENTAL
Intervention: Deliberate practice combined with speech therapy based on the Whole Language Model
Number of subjects: 32

Group type: COMPARATOR
Intervention: Speech therapy based on the Whole Language Model (Control)
Number of subjects: 32
Study: 26663215

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy using methyl aminolaevulinate (MAL, 80 mg g(-1))
Number of subjects: 153

Group type: COMPARATOR
Intervention: Vehicle cream
Number of subjects: 153
Study: 25102461

Group type: EXPERIMENTAL
Intervention: Calcium sulfate hemihydrate (Dentogen)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Calcium hydroxide cement (Dycal)
Number of subjects: 40
Study: 22320349

Group type: EXPERIMENTAL
Intervention: Exenatide (10 µg subcutaneous injection)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 19848573

Group type: EXPERIMENTAL
Intervention: NovoFine 32-gauge tip 6mm needle
Number of subjects: 30

Group type: COMPARATOR
Intervention: Micro Fine Plus 31-gauge 5mm needle
Number of subjects: 30
Study: 17414741

Group type: EXPERIMENTAL
Intervention: Milnacipran 25 mg twice daily, then 50 mg twice daily until the 10th week
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Milnacipran
Number of subjects: 31
Study: 16263999

Group type: EXPERIMENTAL
Intervention: Heliox (70% helium, 30% oxygen) driven nebulized albuterol (15 mg/hour)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Oxygen (100% oxygen) driven nebulized albuterol (15 mg/hour)
Number of subjects: 30
Study: 12537614

Group type: EXPERIMENTAL
Intervention: Voice therapy intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control period of observation
Number of subjects: 0
Study: 9699783

Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroids (early use)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Different drugs or different doses of drug
Number of subjects: 0
Study: 8729740

Group type: EXPERIMENTAL
Intervention: Transdermal glyceryl trinitrate (GTN)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Glycerin (GL) placebo patches
Number of subjects: 63
Study: 2172349

Group type: EXPERIMENTAL
Intervention: Nedocromil sodium, 1% nasal solution, one spray per nostril, four times daily for 8 weeks
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: Cromolyn sodium, 4% nasal solution, one spray per nostril, four times daily for 8 weeks
Number of subjects: 233

Group type: COMPARATOR
Intervention: Placebo, one spray per nostril, four times daily for 8 weeks
Number of subjects: 233
Study: 361156

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 118

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 118
Study: 31898511

Group type: EXPERIMENTAL
Intervention: Preoperative hydroxyzine
Number of subjects: 188

Group type: COMPARATOR
Intervention: Standard procedure with placebo
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Standard procedure with clowns
Number of subjects: 188

Group type: COMPARATOR
Intervention: Standard procedure with placebo and clowns
Number of subjects: 188
Study: 29912307

Group type: EXPERIMENTAL
Intervention: Immediate switch to Dolutegravir (DTG-I)
Number of subjects: 415

Group type: COMPARATOR
Intervention: Deferred switch to Dolutegravir (DTG-D)
Number of subjects: 415

Group type: EXPERIMENTAL
Intervention: Both groups (DTG-I and DTG-D)
Number of subjects: 415
Study: 25554858

Group type: EXPERIMENTAL
Intervention: Er:YAG laser at 250 mJ/4 Hz
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Er:YAG laser at 200 mJ/2 Hz
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (zero cycles)
Number of subjects: 12
Study: 23768444

Group type: EXPERIMENTAL
Intervention: Gastric Bypass (GB)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Sleeve Gastrectomy (SG)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Both GB and SG
Number of subjects: 18
Study: 21639923

Group type: EXPERIMENTAL
Intervention: Chinese herbal medicine (specific formula not detailed)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 19536163

Group type: EXPERIMENTAL
Intervention: High TAC diet (HT)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Low TAC diet (LT)
Number of subjects: 33
Study: 16874594

Group type: EXPERIMENTAL
Intervention: Anorexic exercisers (AE)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Anorexic controls (AC)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Non-anorexic exercisers (NAE)
Number of subjects: 7
Study: 14569412

Group type: COMPARATOR
Intervention: Standard protocol with constant tube current-time settings (4 x 1-mm collimation, 120 kV, 400 mAs(eff))
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Individually weight-adapted tube current-time settings
Number of subjects: 50
Study: 10768804

Group type: EXPERIMENTAL
Intervention: Peer education program
Number of subjects: 9182
Study: 8844923

Group type: EXPERIMENTAL
Intervention: Psychosocial services (more than 45 min)
Number of subjects: 3073

Group type: EXPERIMENTAL
Intervention: Maternal behavioral and psychosocial factors (e.g., smoking, low weight for height, negative mood, rejection of pregnancy)
Number of subjects: 3073

Group type: EXPERIMENTAL
Intervention: Psychosocial services
Number of subjects: 3073
Study: 1727997

Group type: COMPARATOR
Intervention: Single dose of Curosurf (200 mg/kg)
Number of subjects: 343

Group type: EXPERIMENTAL
Intervention: Multiple doses of Curosurf (200 mg/kg initial dose + 2 additional doses of 100 mg/kg each)
Number of subjects: 343
Study: 6091478

Group type: EXPERIMENTAL
Intervention: Ceftriaxone (1 g every 12 hours)
Number of subjects: 197

Group type: COMPARATOR
Intervention: Gentamicin (1 mg/kg every 8 hours) plus Clindamycin (8 mg/kg every 6 hours)
Number of subjects: 197
Study: 30765629

Group type: EXPERIMENTAL
Intervention: Limited resection for lung cancer
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Selective lymph node dissection (SLND)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Radical segmentectomy
Number of subjects: 0
Study: 30429438

Group type: EXPERIMENTAL
Intervention: Xylitol-containing chewing gum, 2 pieces, 7 times/day for 2 days (n = 34)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (no chewing gum, n = 36)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Xylitol-containing chewing gum
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 70
Study: 26856345

Group type: EXPERIMENTAL
Intervention: Patiromer
Number of subjects: 0
Study: 24992147

Group type: EXPERIMENTAL
Intervention: Four translation strategies (educational materials, educational meetings, reminders, audit and feedback)
Number of subjects: 0
Study: 21999476

Group type: EXPERIMENTAL
Intervention: Division of tongue-tie (Group A)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Non-division (Group B)
Number of subjects: 60
Study: 20851080

Group type: EXPERIMENTAL
Intervention: LEISH-F1+MPL-SE vaccine (5, 10, or 20 μg recombinant Leishmania polyprotein LEISH-F1 antigen + 25 μg MPL(®)-SE adjuvant)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 48
Study: 17611080

Group type: EXPERIMENTAL
Intervention: Combination of psychological treatment and anti-psychotic medication
Number of subjects: 41

Group type: COMPARATOR
Intervention: Supportive therapy alone
Number of subjects: 41
Study: 16372586

Group type: EXPERIMENTAL
Intervention: Telmisartan titrated to 40 mg
Number of subjects: 1855

Group type: EXPERIMENTAL
Intervention: Telmisartan titrated to 80 mg
Number of subjects: 1855

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1855
Study: 12789723

Group type: EXPERIMENTAL
Intervention: AK‐2123 (600 mg/m2 on alternate days)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Control (external radiation with telecobalt to a dose of 50 Gy and intracavitary radiation of 20 Gy)
Number of subjects: 98
Study: 11518092

Group type: EXPERIMENTAL
Intervention: Methylphenidate (10 mg dose)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Methylphenidate (higher doses)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 9393912

Group type: EXPERIMENTAL
Intervention: Indomethacin (6-week course)
Number of subjects: 107

Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 107
Study: 7962318

Group type: EXPERIMENTAL
Intervention: 12.5 mg hydrocortisone hemisuccinate
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 25 mg hydrocortisone hemisuccinate
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 250 mg hydrocortisone hemisuccinate
Number of subjects: 6

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 6
Study: 3296264

Group type: EXPERIMENTAL
Intervention: Pyloroplasty
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control (nonuse of pyloroplasty)
Number of subjects: 72
Study: 29484209

Group type: EXPERIMENTAL
Intervention: Carbetocin
Number of subjects: 58

Group type: COMPARATOR
Intervention: Oxytocin
Number of subjects: 58
Study: 27343215

Group type: EXPERIMENTAL
Intervention: Double-bundle (DB) ACL reconstruction with 6- to 8-stranded hamstring autograft
Number of subjects: 80

Group type: COMPARATOR
Intervention: Single-bundle (SB) ACL reconstruction with 6- to 8-stranded hamstring autograft
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both DB and SB ACL reconstruction
Number of subjects: 80
Study: 26180363

Group type: EXPERIMENTAL
Intervention: Lumbar stabilization exercise
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 30
Study: 23860935

Group type: EXPERIMENTAL
Intervention: Unidirectional barbed suture
Number of subjects: 50

Group type: COMPARATOR
Intervention: Polyglactin 910 suture
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 50
Study: 20626151

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment
Number of subjects: 1907

Group type: COMPARATOR
Intervention: Control groups (not specified)
Number of subjects: 1907
Study: 19013463

Group type: EXPERIMENTAL
Intervention: Increasing aspartate aminotransferase (AST) level
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Increasing gamma-glutamyltransferase level
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Increasing AST level
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Increasing white blood cell count
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Decreasing hematocrit
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Model with AST and alanine aminotransferase
Number of subjects: 176
Study: 16815651

Group type: EXPERIMENTAL
Intervention: Estrogen plus progestin (E+P)
Number of subjects: 16608

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16608